MedPath

Effects of Vitamin D supplementation on childhood obesity

Phase 4
Conditions
Childhood Obesity
Registration Number
SLCTR/2015/017
Lead Sponsor
ational Science Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1.Obese children diagnosed based on BMI >2+SD in WHO growth charts
2.Age between 5-15 years

Exclusion Criteria

1.Obesity due to medical treatment (steroids, anti convulsants)
2.Obesity due to endocrine causes (Cushings syndrome, hypoparathyroidism etc.)
3.Obesity due to an identified genetic cause (Prader Willie syndrome etc.).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Insulin resistance using HOMA <br>2. Liver function tests<br>3. Lipid profile<br> [At baseline and at the end of 24 weeks of intervention]<br>
Secondary Outcome Measures
NameTimeMethod
1. Serum calcium<br>2. Urinary calcium to creatinine ratio<br> [3 months after commencement of supplementation]<br>
© Copyright 2025. All Rights Reserved by MedPath